Publication:
Venous and arterial TNF-R1 predicts outcome and complications in acute subarachnoid hemorrhage.

dc.contributor.authorFragata, Isabel
dc.contributor.authorBustamante, Alejandro
dc.contributor.authorPenalba, Anna
dc.contributor.authorFerreira, Patrícia
dc.contributor.authorNunes, Ana Paiva
dc.contributor.authorCanhão, Patrícia
dc.contributor.authorMontaner, Joan
dc.date.accessioned2023-01-25T10:28:44Z
dc.date.available2023-01-25T10:28:44Z
dc.date.issued2019
dc.description.abstractThere is increasing evidence for the role of inflammation in clinical outcome after subarachnoid hemorrhage (SAH). Specifically, the TNF-alfa(α) pathway seems to be relevant after SAH. Although the TNF-α main receptor, TNF-R1 is associated with aneurysm growth and rupture, its relation to prognosis is unknown. We sought to compare TNF-R1 levels in peripheral venous blood and arterial blood closer to the ruptured aneurysm to study the association of TNF-R1 blood levels with poor prognosis (modified Rankin Scale  > 2 at discharge, 3 and 6 months) and complications (hydrocephalus or delayed cerebral ischemia/DCI) following SAH. We included consecutive SAH patients admitted in the first 72 h of symptoms. Blood samples were simultaneously collected from a peripheral vein and from the main parent artery of the aneurysm. Levels of TNF-R1 were measured using enzyme-linked immunosorbent assays. We analyzed 58 patients. Arterial and venous levels of TNF-R1 were correlated (R = 0.706, p  Levels of venous TNF-R1 are associated with poor outcome in SAH. A specific association was found between levels of arterial TNF-R1 and hydrocephalus. These results are consistent with the role of TNF-α pathway in SAH and need to be validated in larger cohorts.
dc.identifier.doi10.1007/s12028-019-00669-9
dc.identifier.essn1556-0961
dc.identifier.pmid30673997
dc.identifier.unpaywallURLhttp://repositorio.chlc.min-saude.pt/bitstream/10400.17/3572/1/Neurocrit%20Care%202019%20107.pdf
dc.identifier.urihttp://hdl.handle.net/10668/13451
dc.issue.number1
dc.journal.titleNeurocritical care
dc.journal.titleabbreviationNeurocrit Care
dc.language.isoen
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationHospital Universitario Virgen Macarena
dc.page.number107-115
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rights.accessRightsopen access
dc.subjectDelayed cerebral ischemia
dc.subjectHydrocephalus
dc.subjectPrognosis
dc.subjectSubarachnoid hemorrhage
dc.subjectTNF-R1
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshArteries
dc.subject.meshCohort Studies
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshPredictive Value of Tests
dc.subject.meshROC Curve
dc.subject.meshReceptors, Tumor Necrosis Factor, Type I
dc.subject.meshSubarachnoid Hemorrhage
dc.subject.meshTreatment Outcome
dc.subject.meshVeins
dc.titleVenous and arterial TNF-R1 predicts outcome and complications in acute subarachnoid hemorrhage.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number31
dspace.entity.typePublication

Files